Table 4.
Late (≥6 months from randomization) toxicity grades per toxicity type and highest grade per individual
| Observation arm | Radiotherapy arm | Overall | |
|---|---|---|---|
| (n = 13) n (%) | (n = 24) n (%) | (n = 37) n (%) | |
| Skin | |||
| 0–2 | 10 (100) | 24 (100) | 34 (100) |
| ≥3 | 0 | 0 | 0 |
| Missing | 3 (23.1) | 0 | 3 (8.1) |
| Subcutaneous tissue | |||
| 0–2 | 9 (100) | 23 (95.8) | 32 (97) |
| ≥3 | 0 | 1 (4.2) | 1 (3) |
| Missing | 4 (30.8) | 0 | 4 (10.8) |
| Mucous membrane | |||
| 0–2 | 7 (100) | 24 (100) | 31 (100) |
| ≥3 | 0 | 0 | 0 |
| Missing | 6 (46.2) | 0 | 6 (16.2) |
| Salivary gland | |||
| 0–2 | 7 (100) | 24 (100) | 31 (100) |
| ≥3 | 0 | 0 | 0 |
| Missing | 6 (46.2) | 0 | 6 (16.2) |
| Nerve damage | |||
| 0–2 | 8 (88.9) | 23 (95.8) | 31 (93.9) |
| ≥3 | 1 (11.1) | 1 (4.2) | 2 (6.1) |
| Missing | 4 (30.8) | 0 | 4 (10.8) |
| Inner ear hearing | |||
| 0–2 | 9 (100) | 23 (95.8) | 32 (97) |
| ≥3 | 0 | 1 (4.2) | 1 (3) |
| Missing | 4 (30.8) | 0 | 4 (10.8) |
| Highest grade per participant | |||
| 0–2 | 9 (90) | 21 (87.5) | 30 (88.2) |
| ≥3 | 1 (10) | 3 (12.5) | 4 (11.8) |
| Missing | 3 (23.1) | 0 | 3 (8.1) |